MedTrace Logo

Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile Dysfunction

NCT07604194 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-22

No results posted yet for this study

Summary

Venous leakage is one of the causes of erectile dysfunction and can be managed using different treatment modalities, including surgical ligation and percutaneous embolization. This randomized clinical trial aims to evaluate and compare the efficacy, durability, safety, side effects, and complications of two treatment procedures-embolosclerotherapy of the periprostatic plexus and deep dorsal vein revascularization-in the management of erectile dysfunction caused by venous leak.

Conditions

  • Erectile Dysfunction Due to Venous Disorder
  • Erectile Dysfunction (ED)

Interventions

PROCEDURE

Endovascular embolosclerotherapy

The goal of endovascular therapy is to achieve adequate embolization of efferent pelvic veins, including the periprostatic and internal or external pudendal veins.

PROCEDURE

Revacularization of deep dorsal vein

Penile venous arterialization of the Deep Dorsal vein using inferior epigastric artery

Sponsors & Collaborators

  • Mansoura University Hospital

    lead OTHER

Principal Investigators

  • Mosaad A Soliman, MD, PhD · vascular surgery department, faculty of medicine, mansoura university

  • khaled A mowafy, MD, PhD · vascular surgery department, faculty of medicine, mansoura university

  • Reem M Soliman, MD, PhD · vascular surgery department, faculty of medicine, mansoura university

  • Ahmed Azhar, MD, PhD, FACS · vascular surgery department, faculty of medicine, mansoura university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-20
Primary Completion
2027-05-20
Completion
2027-09-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07604194 on ClinicalTrials.gov